Andrew Dahlem - 14 Nov 2024 Form 4 Insider Report for Syra Health Corp (SYRA)

Role
Director
Signature
/s/ Deepika Vuppalanchi, as Attorney-in-Fact for Andrew Dahlem
Issuer symbol
SYRA
Transactions as of
14 Nov 2024
Net transactions value
$0
Form type
4
Filing time
18 Nov 2024, 17:07:27 UTC
Previous filing
10 Oct 2023
Next filing
08 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYRA Stock Options Award $0 +11,581 $0.000000 11,581 14 Nov 2024 Class A Common Stock 11,581 $0.3683 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.